Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
Research status Not FDA-approved
Remarkable Results The findings were impressive: BPC-157 Only Group (12 patients): 11 out of 12 patients (91.6%) experienced significant improvement Only 1 patient (8.3%) saw no improvement BPC-157 + TB4 Combination Group (4 patients): 3 out of 4 patients (75%) showed significant improvement 1 patient (25%) experienced no relief Overall Success Rate : 14 out of 16 patients (87.5%) found relief from their knee pain What Makes BPC-157 Different from Traditional Treatments
Targeted Gastrointestinal Support Direct interaction with digestive pathways
The options may be chosen on the product page Sermorelin Injection 3ML 1MG/ML $315.00 or $315.00 Original price was: $315.00.$236.25Current price is: $236.25
US$ 21.06
US$ 29.00
US$ 20.52
US$ 22.06
US$ 27.79
